跳至主要内容
临床试验/ACTRN12611000652976
ACTRN12611000652976终止未知

The effect of PMMA versus PS membrane on mortality in patients with septic acute kidney injury receiving continuous venovenous hemofiltration

Department of intensive care, Pamela Youde Nethersole Eastern Hospital0 个研究点目标入组 120 人开始时间: 2011年6月24日最近更新:
适应症

试验速览

阶段
未知
状态
终止
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • 1.Severe sepsis (defined based on ACCP/ SCCM criteria, ie Systemic Inflammatory Response Syndrome in the presence of suspected or known infection, leading to organ dysfunction), and
  • 2.Acute kidney injury (defined based on RIFLE criteria, Injury” grade or above, who required continuous venovenous hemofiltration support)

排除标准

  • 1.Contraindication for regional citrate anticoagulation (Liver failure or cirrhosis with impaired citrate metabolism, allergy to citrate)
  • 2.Pregnancy
  • 3.Terminal illness

研究者

发起方
Department of intensive care, Pamela Youde Nethersole Eastern Hospital

相似试验